BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 21409202)

  • 1. Multimodality and nanoparticles in medical imaging.
    Huang WY; Davis JJ
    Dalton Trans; 2011 Jun; 40(23):6087-103. PubMed ID: 21409202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zwitterionic Gadolinium(III)-Complexed Dendrimer-Entrapped Gold Nanoparticles for Enhanced Computed Tomography/Magnetic Resonance Imaging of Lung Cancer Metastasis.
    Liu J; Xiong Z; Zhang J; Peng C; Klajnert-Maculewicz B; Shen M; Shi X
    ACS Appl Mater Interfaces; 2019 May; 11(17):15212-15221. PubMed ID: 30964632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratiometric MRI sensors based on core-shell nanoparticles for quantitative pH imaging.
    Okada S; Mizukami S; Sakata T; Matsumura Y; Yoshioka Y; Kikuchi K
    Adv Mater; 2014 May; 26(19):2989-92. PubMed ID: 24453039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convenient synthesis of (68)Ga-labeled gadolinium(III) complexes: towards bimodal responsive probes for functional imaging with PET/MRI.
    Notni J; Hermann P; Dregely I; Wester HJ
    Chemistry; 2013 Sep; 19(38):12602-6. PubMed ID: 24175335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualizing the atherosclerotic plaque: a chemical perspective.
    Teresa Albelda M; Garcia-España E; Frias JC
    Chem Soc Rev; 2014 Apr; 43(8):2858-76. PubMed ID: 24526041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicomponent nanocrystals with anti-Stokes luminescence as contrast agents for modern imaging techniques.
    Generalova AN; Chichkov BN; Khaydukov EV
    Adv Colloid Interface Sci; 2017 Jul; 245():1-19. PubMed ID: 28499601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activatable 19F MRI nanoparticle probes for the detection of reducing environments.
    Nakamura T; Matsushita H; Sugihara F; Yoshioka Y; Mizukami S; Kikuchi K
    Angew Chem Int Ed Engl; 2015 Jan; 54(3):1007-10. PubMed ID: 25413833
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Bouziotis P; Stellas D; Thomas E; Truillet C; Tsoukalas C; Lux F; Tsotakos T; Xanthopoulos S; Paravatou-Petsotas M; Gaitanis A; Moulopoulos LA; Koutoulidis V; Anagnostopoulos CD; Tillement O
    Nanomedicine (Lond); 2017 Jul; 12(13):1561-1574. PubMed ID: 28621567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising strategies for Gd-based responsive magnetic resonance imaging contrast agents.
    Shen C; New EJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):158-66. PubMed ID: 23141598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium oxide nanoparticles as potential multimodal imaging and therapeutic agents.
    Kim TJ; Chae KS; Chang Y; Lee GH
    Curr Top Med Chem; 2013; 13(4):422-33. PubMed ID: 23432005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(acrylic acid) Bridged Gadolinium Metal-Organic Framework-Gold Nanoparticle Composites as Contrast Agents for Computed Tomography and Magnetic Resonance Bimodal Imaging.
    Tian C; Zhu L; Lin F; Boyes SG
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):17765-75. PubMed ID: 26147906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging.
    van Schooneveld MM; Cormode DP; Koole R; van Wijngaarden JT; Calcagno C; Skajaa T; Hilhorst J; 't Hart DC; Fayad ZA; Mulder WJ; Meijerink A
    Contrast Media Mol Imaging; 2010; 5(4):231-6. PubMed ID: 20812290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents.
    Patel D; Kell A; Simard B; Xiang B; Lin HY; Tian G
    Biomaterials; 2011 Feb; 32(4):1167-76. PubMed ID: 21035183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of NaGdF
    Zhang W; Zhang S; Gao P; Lan B; Li L; Zhang X; Li L; Lu H
    Med Phys; 2020 Feb; 47(2):662-671. PubMed ID: 31742714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer.
    Li K; Wen S; Larson AC; Shen M; Zhang Z; Chen Q; Shi X; Zhang G
    Int J Nanomedicine; 2013; 8():2589-600. PubMed ID: 23888113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging.
    Criscione JM; Dobrucki LW; Zhuang ZW; Papademetris X; Simons M; Sinusas AJ; Fahmy TM
    Bioconjug Chem; 2011 Sep; 22(9):1784-92. PubMed ID: 21851119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of nanoparticles in biomedical imaging.
    Han X; Xu K; Taratula O; Farsad K
    Nanoscale; 2019 Jan; 11(3):799-819. PubMed ID: 30603750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paramagnetic solid lipid nanoparticles as a novel platform for the development of molecular MRI probes.
    Rolla GA; Botta M; Tei L; Cabella C; Ghiani S; Brioschi C; Maiocchi A
    Chemistry; 2013 Aug; 19(34):11189-93. PubMed ID: 23843364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors.
    Badea CT; Clark DP; Holbrook M; Srivastava M; Mowery Y; Ghaghada KB
    Phys Med Biol; 2019 Mar; 64(6):065007. PubMed ID: 30708357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.